Drug compounders sue US FDA over removal of Wegovy, Ozempic from shortage list
Drug compounders on Monday sued the U.S. Food and Drug Administration over its decision last week to remove Novo Nordisk's weight loss and diabetes drugs Wegovy and Ozempic from its shortage list, a move that will sharply curtail the compounders' ability to sell cheaper versions of the drugs.
Compounders have filed a lawsuit against the FDA challenging its decision to remove Novo Nordisk's Wegovy and Ozempic from the shortage list. The lawsuit claims the FDA's actions are arbitrary, ...
HealthDay on MSN12h
Ozempic, Wegovy Linked To Potential Vision LossPeople taking the weight-loss drug semaglutide could be at a slightly increased risk for a potentially blinding eye co ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback